These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7389386)

  • 21. [Pindolol-clopamide combination in the treatment of arterial hypertension. Clinical study].
    Meilhac B; Bloch E; Zannier D; Metzger JP
    Therapie; 1983; 38(3):271-4. PubMed ID: 6612663
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hypertension with a fixed combination of pindolol and clopamide (VKB-105)].
    Sekso M; Vizner B; Benković K
    Lijec Vjesn; 1984; 106(11-12):512-4. PubMed ID: 6394939
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of viskaldix in the treatment of patients with hypertension].
    Mikunis RI; Klipatskiĭ AA; Monastyrskiĭ IuI; Kirichenko VI; Pshelutskiĭ FF
    Klin Med (Mosk); 1988 Oct; 66(10):62-4. PubMed ID: 3070156
    [No Abstract]   [Full Text] [Related]  

  • 24. [Should elderly hypertensive patients be treated with a beta-blocker-diuretic combination?].
    Böhmer F
    Z Gerontol; 1984; 17(2):89-92. PubMed ID: 6730636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hypertension with a combination of prindolol and clopamide (author's transl)].
    Gábor G; Jávor T; Szám I; Török E
    MMW Munch Med Wochenschr; 1975 Nov; 117(46):1853-6. PubMed ID: 811982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
    Med J Aust; 1989 Jun; 150(11):646, 648, 651-2. PubMed ID: 2657348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viskaldix in the treatment of essential hypertension. A study on hospital out-patients.
    Cameron EG; Crowder D
    Practitioner; 1981 Apr; 225(1354):581-5. PubMed ID: 7279846
    [No Abstract]   [Full Text] [Related]  

  • 28. A beta blocker-thiazide combination in the treatment of hypertension in diabetics.
    Chazan BI; Old JM; Venkataraman G; Snape J; Cameron EG
    Br J Clin Pract; 1981; 35(11-12):393-8. PubMed ID: 7030375
    [No Abstract]   [Full Text] [Related]  

  • 29. [Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study].
    Werning C; Hammerschmidt D; Kaiser Hj
    Med Welt; 1978 Oct; 29(40):1570-5. PubMed ID: 703579
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effectiveness of Viskaldix in patients with primary hypertension].
    Cybulska I; Sznajderman M
    Pol Tyg Lek; 1983 Nov; 38(45):1399-401. PubMed ID: 6374634
    [No Abstract]   [Full Text] [Related]  

  • 31. A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension.
    Seedat YK; Rawat R
    S Afr Med J; 1984 Nov; 66(18):682-4. PubMed ID: 6387966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial blood pressure and various biochemical parameters in the blood of patients with idiopathic hypertension treated with Viskaldix].
    Wiecek A; Kargul W; Gasior Z; Grzeszczak W
    Wiad Lek; 1985 Jul; 38(13):912-9. PubMed ID: 4060720
    [No Abstract]   [Full Text] [Related]  

  • 33. Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the betablocker pindolol.
    Schiffl H; Weidmann P; Mordasini R; Riesen W; Bachmann C
    Metabolism; 1982 Apr; 31(4):411-5. PubMed ID: 7043175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of the treatment with pindolol and clopamide on left-ventricular systolic and diastolic time intervals in patients with moderate primary arterial hypertension].
    Gross-Sawicka E; Wyrzykowski B; Krupa-Wojciechowska B
    Pol Tyg Lek; 1988 Jul; 43(27):885-8. PubMed ID: 3072538
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antihypertensive effectiveness of a guanfacine/clopamide combination].
    Wetzels E; Weidinger G
    MMW Munch Med Wochenschr; 1982 Oct; 124(40):871-4. PubMed ID: 6815503
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations with Viskaldix, a combined antihypertensive agent.
    Gyimesi A; Hanyec V; Pocsay G; Lörinczy E; Iványi J
    Ther Hung; 1987; 35(3):147-51. PubMed ID: 3326209
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of hemodynamic changes in patients with primary arterial hypertension after treatment with a combination of pindolol and clopamide (Viskaldix)].
    Wyrzykowski B; Suchecka-Rachoń K
    Kardiol Pol; 1991; 34(5):286-91. PubMed ID: 1921111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term Viskaldix therapy in the treatment of hypertensive patients.
    Dudás M; Iványi J
    Ther Hung; 1985; 33(3):152-5. PubMed ID: 3842011
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemodynamic effects of hydrochlorothiazide, propranolol and a combination of pindolol and clopamide in patients with essential hypertension].
    Meza N; López H; Román O
    Rev Esp Cardiol; 1989 May; 42(5):304-8. PubMed ID: 2772366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Field study results of a fixed beta blockader-diuretic combination: effect of dosage reduction ("stepping down")].
    Wyrsch J; Bousquet JC
    Schweiz Rundsch Med Prax; 1983 Oct; 72(40):1279-81. PubMed ID: 6647391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.